Transcriptional regulation of mouse μ opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the μ opioid receptor gene

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1674-1683

  Choi, Hack Sun ^a   Hwang, Cheol Kyu ^a   Kim, Chun Sung ^a   Song, Kyu Young ^a   Law, Ping Yee ^a   Wei, Li Na ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MU OPIATE RECEPTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP3 M1; TRANSCRIPTION FACTOR SP3 M2; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; CHROMATIN; CONTROLLED STUDY; DNA FLANKING REGION; DROSOPHILA MELANOGASTER; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; MICE; NEURONS; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 17844365014     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.008284     Document Type: Article

References (35)

1. Ammanamanchi S and Brattain MG (2001) Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. J Biol Chem 276:3348-3352.
2. Choe C, Im HJ, Ko JL, and Loh HH (1998) Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter. J Biol Chem 273:34926-34932.
3. Courey AJ and Tjian R (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
4. Donahoe RM and Vlahov D (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83:77-87.
5. Hwang CK, D'Souza UM, Eisch AJ, Yajima S, Lammers CH, Yang Y, Lee SH, Kim YM, Nestler EJ, and Mouradian MM (2001) Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc Natl Acad Sci USA 98:7558-7563.
6. Hwang CK, Kim CS, Choi HS, McKercher SR, and Loh HH (2004) Transcriptional regulation of mouse mu opioid receptor gene by PU. 1. J Biol Chem 279:19764-19774.
7. Hwang CK, Wu X, Wang G, Kim CS, and Loh HH (2003) Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins. J Biol Chem 278:3742-3750.
8. Ikeda K, Kobayashi T, Ichikawa T, Kumanishi T, Niki H, and Yano R (2001) The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice. J Neurosci 21:1334-1339.
9. Im HJ, Smirnov D, Yuhi T, Raghavan S, Olsson JE, Muscat GE, Koopman P, and Loh HH (2001) Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol 59:1486-1496.
10. Kennett SB, Moorefield KS, and Horowitz JM (2002) Sp3 represses gene expression via the titration of promoter-specific transcription factors. J Biol Chem 277:9780-9789.
11. Kennett SB, Udvadia AJ, and Horowitz JM (1997) Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 25:3110-3117.
12. Kieffer BL (1995) Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 15:615-635.
13. Kieffer BL (1999) Opioids: first lessons from knockout mice. Trends Pharmacol Sci 20:19-26.
14. Ko JL, Chen HC, and Loh HH (2002) Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res Mol Brain Res 104:184-193.
15. Ko JL, Liu HC, and Loh HH (2003) Role of an AP-2-like element in transcriptional regulation of mouse micro-opioid receptor gene. Brain Res Mol Brain Res 112:153-162.
16. Ko JL, Liu HC, Minnerath SR, and Loh HH (1998) Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem 273:27678-27685.
17. Ko JL and Loh HH (2001) Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem 276:788-795.
18. Ko JL, Minnerath SR, and Loh HH (1997) Dual promoters of mouse mu-opioid receptor gene. Biochem Biophys Res Commun 234:351-357.
19. Kraus J, Borner C, Giannini E, and Hollt V (2003) The role of nuclear factor κB in tumor necrosis factor-regulated transcription of the human μ-opioid receptor gene. Mol Pharmacol 64:876-884.
20. Law PY, Wong YH, and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430.
21. Lee PW and Lee YM (2003) Transcriptional regulation of mu opioid receptor gene by cAMP pathway. Mol Pharmacol 64:1410-1418.
22. Majello B, De Luca P, and Lania L (1997) Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272:4021-4026.
23. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, and Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature (Lond) 388:586-589.
24. Mansour A, Fox CA, Akil H, and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29.
25. Mao X, Moennan AM, and Barger SW (2002) Neuronal kappa B-binding factors consist of Sp1-related proteins. Functional implications for autoregulation of N-methyl-D-aspartate receptor-1 expression. J Biol Chem 277:44911-44919.
26. Min BH, Augustin LB, Felsheim RF, Fuchs JA, and Loh HH (1994) Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci USA 91:9081-9085.
27. Nyland SB, Specter S, Im-Sin J, and Ugen KE (1998) Opiate effects on in vitro human retroviral infection. Adv Exp Med Biol 437:91-100.
28. Pan YX (2002) Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Opnn) that generates eight splice variants. Gene 295:97-108.
29. Pan YX, Xu J, Mahurter L, Bolan E, Xu M, and Pasternak GW (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci USA 98:14084-14089.
30. Schneider I (1972) Cell lines derived from late embryonic stages of Drosophila melanogaster. J Embryol Exp Morphol 27:353-365.
31. Sedqi M, Roy S, Ramakrishnan S, Elde R, and Loh HH (1995) Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun 209:563-574.
32. Sheng WS, Hu S, Gekker G, Zhu S, Peterson PK, and Chao CC (1997) Immunomodulatory role of opioids in the central nervous system. Arch Immunol Ther Exp (Warsz) 45:359-366.
33. Wang G, Wei LN, and Loh HH (2003) Transcriptional regulation of mouse 8-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse 8-opioid receptor gene in Neuro2A cells. J Biol Chem 278:40550-40556.
34. Wei LN and Loh HH (2002) Regulation of opioid receptor expression. Curr Opin Pharmacol 2:69-75.
35. Won J, Yim J, and Kim TK (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 277:38230-38238.